These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31241130)
1. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction. Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130 [TBL] [Abstract][Full Text] [Related]
2. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein. Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X J Biosci; 2021; 46():. PubMed ID: 33576342 [TBL] [Abstract][Full Text] [Related]
3. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion. Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
5. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway. Zhang Q; Wang Y Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC. Liao Z; Zheng Q; Wei T; Zhang Y; Ma J; Zhao Z; Sun H; Nan K Oncol Res; 2020 Mar; 28(2):147-159. PubMed ID: 31711559 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3Cβ(D1067V) kinase domain mutation. Pazarentzos E; Giannikopoulos P; Hrustanovic G; St John J; Olivas VR; Gubens MA; Balassanian R; Weissman J; Polkinghorn W; Bivona TG Oncogene; 2016 Mar; 35(9):1198-205. PubMed ID: 25982275 [TBL] [Abstract][Full Text] [Related]
8. Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma. Lissanu Deribe Y; Shi Y; Rai K; Nezi L; Amin SB; Wu CC; Akdemir KC; Mahdavi M; Peng Q; Chang QE; Hornigold K; Arold ST; Welch HC; Garraway LA; Chin L Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1296-305. PubMed ID: 26884185 [TBL] [Abstract][Full Text] [Related]
9. Interplay between PREX2 mutations and the PI3K pathway and its effect on epigenetic regulation of gene expression in NRAS-mutant melanoma. Lissanu Deribe Y Small GTPases; 2016 Jul; 7(3):178-85. PubMed ID: 27111337 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway. Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302 [TBL] [Abstract][Full Text] [Related]
13. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent. Ko H; Ahn HJ; Kim YI Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114 [TBL] [Abstract][Full Text] [Related]
14. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
15. Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer. Sun H; Ma H; Wang J; Xia L; Zhu G; Wang Z; Sun J; Chen Z Tumour Biol; 2017 Jul; 39(7):1010428317709639. PubMed ID: 28714370 [TBL] [Abstract][Full Text] [Related]
16. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis. Hodakoski C; Hopkins BD; Barrows D; Mense SM; Keniry M; Anderson KE; Kern PA; Hawkins PT; Stephens LR; Parsons R Proc Natl Acad Sci U S A; 2014 Jan; 111(1):155-60. PubMed ID: 24367090 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma. Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209 [TBL] [Abstract][Full Text] [Related]
18. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung. Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling. He S; Lin J; Yu S; Sun S Oncol Lett; 2016 Mar; 11(3):2223-2228. PubMed ID: 26998152 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA TTN-AS1 promotes the progression of lung adenocarcinoma by regulating PTEN/PI3K/AKT signaling pathway. Luo J; Liu Z Biochem Biophys Res Commun; 2019 Jun; 514(1):140-147. PubMed ID: 31027732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]